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LABORATORY AND FIELD INVESTIGATIONS WITH DIFENACOUM, A PROMISING NEW RODENTICIDE 
JOHN O. BULL, Rodenticides Section, Plant Protect ion Division, Imperial  Chemical Industr ies, Fernhurst,                         
Haslemere, Surrey, England 
ABSTRACT:  Difenacoum is a new rodenticide recently introduced on the British market; it is one of 
the most potent of a series of hydroxycoumarin-based anticoagulants.  Difenacoum is effective 
against laboratory rats and mice resistant to conventional anticoagulants and has a marked 
selectivity in favour of non-target species.  Vitamin K1 is an effective antidote and the hazard of 
secondary poisoning is minimal.  Laboratory and field trials confirm difenacoum's efficacy against 
wild resistant strains.  Further work is in progress to evaluate the efficacy of difenacoum against 
other rodent pest species. 
INTRODUCTION 
The rapid introduction of warfarin into the United Kingdom during the early 1950's provided a 
much needed boost to the control of rats and mice and there was a short period during which rodent 
control was easier but at the same time, more effective.  This Utopian situation did not last long.  
Rats resistant to both warfarin and diphacinone were soon confirmed in the Scottish Lowlands (Boyle, 
1960); anticoagulant resistance was also noted in mice (Dodsworth, 1961).  Since then, the incidence 
of resistance has increased considerably, not only in the UK but in other countries, notably the 
United States (Brooks and Bowerman, 1975; Jackson et al., 1975). 
In contrast with the comparative abundance of alternative pesticides in agriculture, there was no 
immediate replacement for warfarin and other anticoagulants.  Since 1960, much effort has been expended 
in the UK by Government (Rowe et al., 1970) and private companies (Bull, 1967) to find alternative 
compounds. 
Routine screening of toxic materials rejected by the pharmaceutical industry for human use proved 
time consuming and few compounds reached even the field trials stage (Rowe, 1970).  Routine synthesis of 
new compounds in the pharmaceutical industry has thrown up very few promising new rodenticides, notably 
norbormide, parachlorphenyl silatrane (Beiter et al., 1970) and a series of compounds from Rohm & Haas 
(Peardon, 1974). The two former compounds have not fulfilled their initial promise (Rennison et al., 
1968) and are now little used, while only one of the Rohm & Haas series (787) has reached registration 
and marketing in the United States. 
A more fundamental approach was adopted by Hadler and Shadbolt (1975) who, after carefully 
examining the current evidence on anticoagulant resistance and coagulation theory, proceeded to 
synthesize a series of hydroxycoumarin-based anticoagulants, many of which showed exceptional potency to 
both normal and anticoagulant resistant rats.  One of the most potent of the series is 3-(3-P-dipheny1-
1,2,3,4-tetrahydronaphth-1-yl)-4-hydroxycoumarin, the proposed British Standard Common name being 
difenacoum.  The present paper examines the properties and toxicity of difenacoum and reviews laboratory 
and field performance in the UK and other parts of the world. 
STRUCTURE OF DIFENACOUM 
The anticoagulant coumatetraly1 has a higher activity than warfarin against resistant strains of 
Rattus norvegicus (Lund, 1972) possibly related to the size and complexity of the groups attached to the 
4-hydroxycoumarin.  The rationale of Hadler and Shadbolt (loc. cit) in synthesizing compounds with 
substituted phenyl groups attached by a three carbon chain to the 4-hydroxycoumarin moiety is 
illustrated in Figure 1.  Fuller details of the chemistry and structure/activity relationships are given 
in the original paper. 
 
TOXICITY  
 
a) Acute
 Difenacoum is highly active against a number of important rodent species (Table 1). In 
contrast with warfarin, difenacoum is more toxic to the Mus musculus than to Rattus norvegicus.    
Although the data are limited, the susceptibilities of Rattus rattus and its  
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Figure 1.  Comparative structures of three  
rodenticides. 
sub-species are of the same order as that of R. norvegicus.  This again contrasts with 
warfarin since R. rattus has required a concentration about five times more than that for R. 
norvegicus (Bentley and Larthe, 1959). 
For non-target species, difenacoum is much less toxic; in particular the pig is far 
less susceptible than to warfarin (Papworth, 1958) for which a dose of 1 mg/kg has been 
recorded as lethal.  
b)  Chronic
Groups of male Wistar rats and male LAC mice were given a graded series of doses of 
difenacoum on five consecutive days to establish its cumulative toxicity vis-a-vis warfarin. The 
chronic oral LD50 was established as 5 x 0.15 mg/kg for rats and 5 x 0.07 mg/kg for mice. In 
each instance the cumulative dose was about half of the acute.  A similar test on homozygous 
resistant (Welsh strain) R. norvegicus gave 5 x 0.54 mg/kg, from which a resistance factor of 
about x 3 can be deduced in comparison with non-resistant animals.  
At first sight, the activity of difenacoum seems to differ from warfarin for which the 
ratio of acute to chronic dose is taken to be large, i.e. > 50 mg/kg:  5 x 0.5 mg/kg (Hayes and 
Gaines, 1950).  Reviewing other work on warfarin, Bentley and Larthe (1959) list acute oral LD50 
values ranging from 1.3-323 mg/kg the most widely quoted being 60 mg/kg.  Because of these 
disparities and to allow valid comparison of warfarin with difenacoum, new  
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determinations have been made.  The oral LD50 of high purity warfarin in glycol solution  to 
female rats was 8.5 mg/kg, 95% confidence limits 4-15 mg/kg (M.Hadler, personal communication).  
The LD50 of an aqueous suspension of warfarin was 6.9 mg/kg, 95% confidence limits 4.3-ll (R. 
Parkinson, personal communication). 
These data on warfarin indicate that the ratio of chronic to acute is less than has been 
widely accepted and that the safety margin may be less than has been supposed. Further work is 
in progress to resolve the apparent discrepancy. 
c)  Hazards to domestic animals
High potency per se is sometimes taken out of context and without reference to the end-use 
concentration.  Data is therefore included on various rodenticide to compare their hazards to non-
target species (Table 2).  The calculations for warfarin are based on early published work and 
take no account of the data given in the previous paragraph.  The margins of safety offered by 
difenacoum need no further comment. 
Table 2.  Amount of bait (grams) required to deliver 1 acute LD50 dose of various  rodenticides       
to different species. 
 
 
TOXICITY OF IMPURITIES PRESENT IN DIFENACOUM 
Analysis shows two main impurities in difenacoum; 4-hydroxycoumarin and 2-p-diphenyl -1,2-
dihydronaphthalene. Oral dosing of these compounds in polyethylene glycol to mice gave acute oral 
LD50’s of >200 mg/kg and 180 mg/kg respectively.  The corresponding LD50 for difenacoum against  
mice is 0.8 mg/kg and since neither of the impurities is present at more than 2-3% in technical 
difenacoum they can be ignored as toxic components. 
ANTICOAGULANT ACTIVITY 
The structure, method of synthesis and mode of action of difenacoum are a l l  character-
i s t i c  of a classical indirect anticoagulant.  The activity of difenacoum was compared with 
that of some other commonly used anticoagulants against Wistar Rats (Fig. 2); the most active 
of the warfarin isomers (s-) was the least effective compound tested and difenacoum the most 
effective with the other three compounds b e i n g  intermediate.  For homozygous resistant (Welsh 
strain) rats, differences between compounds were enormous (Fig. 3).  The resistance factors 
between the strains varied from x 2 for difenacoum to about x 227 for diphacinone       
(Hadler, 1975a). 
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 Figure 3.  The effect on the extension of prothrombin times of 
homozygous resistant (Welsh strain) male rats following three 
daily oral administrations of various rodenticides. 
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ANTIDOTE STUDIES 
Vitamins K and K  were tested as possible antidotes to difenacoem. As expected,  3  1
Vitamin K was almost inactive; Vitamin K  was much more effective.  A single dose of 2    3 1
mg/kg difenacoum k i l l e d  8/10 male mice (Fig. 4) w h i l e  only 2/10 d i e d  when protected by 
d a i l y  injections of 10 mg/kg V i t a m i n  K1.  More d e t a i l e d  examination of the optimum dose for 
rats (Hadler, in preparation) has shown that doses of 10 mg/kg V i t a m i n  K1 w i l l  provide 
effective protection against difenacoum at a l l  levels up to 50 mg/kg.  T h is  compares w i t h  
work on warfarin for which 1 mg/kg V i t a m i n  K1 w i l l  protect against any level (Lowenthal and 
Macfarlane, 1964; Lowenthal and Birnbaum, 1969). The higher level of V i t a m i n  K1 required 
for difenacoum may o n l y  reflect the higher potency of the rodenticide but the data also 
i n d i c a t e  the prolonged action of difenacoum and underline the need for careful monitoring of 
antidotal measures taken in instances of accidental poisoning.  However the delay of up to 
three days before death occurs is more than adequate time for i n s t i g a t i o n  of effective 
prophylactic measures. 
               Figure 4.  The effect of Vitamin K1 in reversing the anticoagulant 
action of a single dose of difenacoum given to LAC mice. 
SECONDARY TOXICITY 
Anticoagulants in general have a good record regarding toxicity to predators feeding 
on poisoned rodents.  The possible hazard of difenacoum was elevated by feeding poisoned 
mice to rats for either one or three days. 
Determination of rat prothrombin times 24 hours after completion of feeding showed 
s l i g h t l y  greater elevation with warfarin than with difenacoum for the one day feed (Table 3); 
the situation was reversed for the three day feed, probably the result of the more prolonged                
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action of difenacoum. However the results are s u f f i c i e n t l y  close to suggest that difenacoum 
is u n l i k e l y  to offer significantly greater hazard than warfarin to non-target species. 
Table 3.  The effect on prothrombin times of rats fed w i t h  difenacoum poisoned mice. 
 
LONG TERM FEEDING STUDIES 
Although all available evidence showed that difenacoum acted only as an indirect 
anticoagulant, laboratory rats and mice were fed continuously with low concentrations of 
difenacoum (0.1 ppm and 0.5 ppm respectively) in their diet for 12 weeks to elucidate other 
possible effects. During this period 3.13 mg/kg was consumed by rats and 1.48 mg/kg by 
mice (about 2  LD50'S  in each case). Four out of 12 male rats died in weeks 10 and 11 and 
one female in week eleven; only 2/25 male mice died. All deaths were attributable to 
classical anticoagulant hemorrhaging; moreover, histological examination detected no 
abnormalities in the organs of animals of either species. 
BAIT FEEDING STUDIES 
Baits were fed to homozygous resistant R. norvegicus to compare the activity of 
difenacoum with other rodenticides. Coumatetralyl again showed its superiority over other 
conventional anticoagulants but was much less effective than difenacoum which gave signifi-
cant mortality even at 10 ppm (Table 4). 
Table 4.  Ten day no choice bait trials in female homozygous resistant (Welsh strain
R. norvegicus1. 
 
 
                                                                                  
 
 
 More detailed studies at the Toworth Laboratories of the Ministry of Agriculture, 
Fisheries and Food on 0.005% difenacoum bait were made with R. norvegicus, R. rattus and Mus 
musculus (Hadler, Redfern and Rowe, 1975).  These tests confirmed the efficacy of difenacoum 
in two day no-choice feeding (Table 5).  Non-resistant rats were all killed; 9/10 and 5/10 
respectively of the resistant strains succumbed.  Mice were less susceptible with 9/10 non-
resistant and 13/15 resistant mice being killed. In similar tests with warfarin, a kill of 
21/23 was obtained with non-resistant rats (Bentley and Larthe, loc. cit.) whereas no 
resistant rats would die. 
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Choice tests were carried out on the three species using different feeding periods with 
various concentrations (Table 6). High concentrations of difenacoum were clearly unacceptable to 
M. musculus and R. norvegicus; at 0.005% there was still some discrimination by the latter 
against difenacoum but kills were excellent.  A further test comparing the acceptance of 0.025% 
warfarin with 0.005% difenacoum showed insignificant preference for difenacoum. 
Further tests on house mice in large pens confirmed that longer feeding periods were 
required to get good control and that slightly higher concentrations might be required (Table 
7). However the Cambridge strain of mice used in this experiment is known to have exceptional 
resistance to anticoagulants; field strains are likely to be more susceptible and more readily 
controlled by difenacoum than the results above would suggest. 
Table 7.  Summary of tests on house mice in pens (after Rowe, 1975). 
% Difenacoum No. mice No. killed % kill Days to death 
tested 
0.005% 81 72 89 3-23 
0.010% 67 65 97 3-15 
FIELD TRIALS 
Difenacoum was tested on a number of farms in Wales and in Kent, since the resistant rats 
in these two areas probably represented different genetic strains (Rennison and Hadler, 1975). 
Three farms were treated first with 0.025% warfarin and, not unexpectedly, all treatments were 
unsuccessful; the farms were then treated with 0.005% difenacoum and the rat infestations were 
eradicated (Fig. 5). Eleven further farms were treated with 0.005% difenacoum and six farms with 
0.010% difenacoum.  The results showed that difenacoum effectively controlled warfarin resistant 
rats in both areas; no practical difference could be demonstrated between the two concentrations 
used and the lower concentration was therefore, chosen for field use. Since Autumn 1974, 
difenacoum (under the trade name of "NeoSorexa", registered trade mark of Ward Blenkinsop & Co. 
Ltd.) bait has been commercially available to professional pest control operators, local 
authorities and large agricultural users and has proved remarkably successful. 
TESTS ON OTHER STRAINS AND SPECIES 
Difenacoum at 0.01% has also been tested against American strains of anticoagulant 
resistant R. norvegicus (Table 8) as well as R. r. mindanensis from the Philippines and R. 
exulans from Hawaii (Scott, DWRC, personal communication). The results were promising and further 
work is planned to test difenacoum under field conditions. Preliminary tests by Brooks and  
Bowerman (personal communication) conducted on five resistant Norway rats from Chicago gave 100% 
mortality with 0.005% difenacoum after a 6 day  no-choice feeding  test. One hundred percent 
mortality of eight resistant house mice (Mus musculus) was also obtained after a 21 day no-choice 
test with 0.005% difenacoum. Jackson (personal communication) has also conducted preliminary 
laboratory trials with 0.005% difenacoum baits on 10 Chicago resistant rats with complete 
mortality after a 6 day, no-choice test. In view of these results and preliminary genetic data 
obtained for American resistant rats by Brooks and Bowerman (loc. cit), it is expected that 
difenacoum will perform well under American conditions. 
Danish resistant rats (Lund, 1975) all died when subjected to the standard 6 day 
feeding regime (Table 9). 
Evaluations of difenacoum against Rattus tiomanicus, an important pest of oil palm, and              
Rattus argentiventer a rice field rat have shown promising results (B.J. Wood, personal 
communication).  Difenacoum at 0.01% killed all R. tiomanicus whether they ate 20g bait/day or 
were restricted to 5g (Fig. 6). Even 0.001% under the latter regime killed nearly 90% of rats. 
Comparative field trials in oil palm have confirmed the promise of laboratory tests (Table 10:  
B.J. Wood, personal communication). Difenacoum at  0.0055% gave equivalent  results to warfarin  
at 0.05% but  0.0275% difenacoum was  more  effective in that half the previous number of rounds 
and  baits were needed to obtain control. Further work is planned to determine the optimum 
concentration for use against R. argentiventer. 
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Figure 5. The regression of rat populations on three farms after 
treatment with 0.025% warfarin (broken lines) and afterwards with 
0.005% difenacoum (solid lines). Taken from Rennison and Hadler, 1975. 
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Table 10. Results of field trials with difenacoum-based wax cubes against Rattus tiomanicus   
under oil palms. 
      Arvicanthis  niloticus (Nile, grass or harsh furred rat) is a serious agricultural pest 
in Africa and parts of the Arabian peninsula. From comparative laboratory tests (Gill and  
Redfern, Pans in  press) it appears that there is a factor of about x 7 in toxicity  of 0.005% 
difenacoum over 0.025% warfarin; 100% kill was achieved after 2-3 days no choice feeding 
compared with 5-6 days with warfarin. Overall, the susceptibility of Arvicanthis to difenacoum 
appears to fall between that of R. norvegicus and R. rattus (Anon., 1970). Gill and Redfern 
conclude that all the rodenticides tested, in suitable bait formulations, would be effective as 
practical control agents but rightly stress the need for practical field evaluation before 
definite conclusions can be drawn. 
CONCLUSIONS 
Difenacoum is still in an early stage of development and much work remains to be done but 
the product appears to be one of the most exciting developments in rodent control for many 
years. It has all the benefits of the 'classical' anticoagulants and a wide spectrum of action 
against rodents, with the additional advantages of being active against anticoagulant 
resistant rats and having a marked degree of selectivity towards non-target species. 
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